- Home
- THR vs AUPH Comparison
THR vs AUPH Comparison
Compare THR & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THR | AUPH |
|---|---|---|
| Founded | 1954 | 1993 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2011 | 1999 |
Fundamental Metrics
Financial Performance| Metric | THR | AUPH |
|---|---|---|
| Price | $38.52 | $16.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 429.1K | ★ 1.4M |
| Earning Date | 02-05-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.04 | N/A |
| EPS | ★ 1.75 | 0.55 |
| Revenue | ★ $509,054,000.00 | $265,808,000.00 |
| Revenue This Year | $4.87 | $21.22 |
| Revenue Next Year | $4.78 | $15.40 |
| P/E Ratio | ★ $22.00 | $29.41 |
| Revenue Growth | 3.08 | ★ 20.62 |
| 52 Week Low | $23.05 | $6.55 |
| 52 Week High | $41.20 | $16.48 |
Technical Indicators
Market Signals| Indicator | THR | AUPH |
|---|---|---|
| Relative Strength Index (RSI) | 60.61 | 62.79 |
| Support Level | $37.27 | $15.57 |
| Resistance Level | $41.20 | $16.07 |
| Average True Range (ATR) | 1.69 | 0.49 |
| MACD | -0.26 | -0.07 |
| Stochastic Oscillator | 58.76 | 85.29 |
Price Performance
Historical ComparisonAbout THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.